Genetic Engineering & Biotechnology News
Genetic Engineering & Biotechnology News (known around the world as GEN) is the leading publication in the global biotech market
With critical mass readership of over 175,000 in print, at the highest frequency of publication in the sector, and up to 600,000 user sessions (incl aggregated) on GEN’s website each month, GEN offers marketers maximum impact and reach deep within the commercial life sciences sector, the ability to further develop a leading profile, increase brand awareness, drive sales by acquiring new customers and growing their existing customer base.
GEN print, digital and integrated channels give options for branding, product launches, sustained product sales promotion and lead generation, including:
- Space Advertising including covertips – with contextual positioning in relevant editorial
- Supplements, tip-ins and inserts, including cds, business reply card attachments to print ads
- Classified Ads for jobs, services and conference / meeting ads
- New Product Services – editorial and advertising
- Product Launch Packages – see case studies or email for a specific package to be tailored for you
- Web banners on www.genengnews.com – GEN’s companion website, with news updated every 20 minutes
- Banners on email newsletters - Table of Contents email Alert and Daily / Weekly News email Newsletters
- Single-sponsored html e-newsletters with, exclusive subject sponsorship, audience category selection
- Podcasts - weekly provocative editorial interviews with biotech newsmakers
- Webinars
- Video hosting
- Microsites - GEN content relevant to sponsor, together with sponsor's content, eg White Papers, Application Notes, Videos
- Print and online supplements
Please see print or digital information for each option, or for to request reader demographics, samples of print and digital options, or quotes for a specific need, email hturnbull@impressmedia.com
96% of GEN subscribers are actively involved in driving the technology evaluation and purchasing process - Lewis & Clark Independent Study
84.4% of GEN subscribers take one or more actions in response to advertisements in GEN - Lewis & Clark Independent Study